Sildenafil Citrate Tablet, Film Coated
Product Images NDC 82868-094

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 82868-094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (82868 094 30 Rev A 11 25 Nhc)

Label (82868 094 30   Rev A 11 25 Nhc)
This is a description of Sildenafil tablets in 20mg strength, with 30 tablets in the package. The tablets are prescription-only (Rx Only) and should be stored at a temperature between 20° - 25°C (68° - 77°F). It is advised to keep the medication out of the reach of children and store it in the original container. The product was repackaged by Northwind Health Company, located in Indianapolis, IN 46203. The GTIN code is 00382668094309, and the product has serial number 0000000000000, expiry date 00/00/0000, and lot number 0000000000.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 06)

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 07)

Graph (Sildenafil Tablets Usp 20mg Figure 07)
This text contains information about interacting drug fold change and 90% CI recommendations for various medications and their dose adjustments. It includes details on drugs like Acitomycin, Bosentan, Cimetidine, Evomyeint, Maslox, Oral Contraceptives, Rionavit, and Sapionis K8. The text also mentions the change in relative to Sildenafil alone and specifies that there is no benefit on exercise capacity when Sildenafil is added to bosentan therapy. This information can be used for understanding drug interactions and making informed dosing decisions.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 08)

Graph (Sildenafil Tablets Usp 20mg Figure 08)
This text provides information about drug interactions involving Acenocoumarol and various other drugs like Aspirin, Atorvastatin, and Ethinyloestradiol. It includes recommendations related to fold changes and 90% confidence intervals for different parameters like INR and Cmax. The document also mentions specific dosages for drugs like Doxazosin and provides a caution against coadministration in certain cases. It further discusses the impact of ritonavir on sildenafil PK and a lack of exercise capacity improvement when sildenafil is added to bosentan therapy.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 09)

Graph (Sildenafil Tablets Usp 20mg Figure 09)
This text provides information on the change in distance from the baseline in meters for different groups over weeks 4, 8, and 12 of the study. The study involves participants receiving either a placebo, Sildenafil 20mg TID, Sildenafil 40mg TID, or Sildenafil 80mg TID. The data presented shows the change in distance after treatment with the different dosages of Sildenafil.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 10)

Graph (Sildenafil Tablets Usp 20mg Figure 10)
This text appears to be a medical data related to a study involving the use of Sildenafil (20mg three times a day) compared to Placebo in patients with idiopathic Pulmonary Arterial Hypertension (PAH). The data includes baseline walk distance, PH criteria for functional capacity, gender distribution, age, Mean Pulmonary Artery Pressure (PAP), and a graph showing Placebo-corrected Change in 6-Minute Walk Distance over time. The study seems to assess the impact of Sildenafil on exercise capacity in patients with PAH.*
FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 11)

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 12)

Graph (Sildenafil Tablets Usp 20mg Figure 12)
This text provides data on the change from baseline in meters for different doses of Sildenafil (1mg, 5mg, and 20mg) administered thrice daily up to week 12 of the study. The plot shows the mean change from baseline along with the Standard Error for each treatment at every visit throughout the 12 weeks.*
FDA Label Image

Structure Formula (Sildenafil Tablets Usp 20mg Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.